1-3 of 3
Thomas Kurz
Close
Sort by
Journal Articles

Therapeutic Targeting of HSP90 in AML and ALL

Sanil Bhatia, PhD, Heinz Ahlert, Msc, Benedikt Frieg, PhD, Arndt Borkhardt, MD, Holger Gohlke, PhD, Thomas Kurz, Julia Hauer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4680.
https://doi.org/10.1182/blood-2018-99-120362
Published: 2018
Journal Articles

Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response

Sanil Bhatia, Daniela Diedrich, Benedikt Frieg, Heinz Ahlert, Stefan Stein, Bertan Bopp, Franziska Lang, Tao Zang, Tobias Kröger, Thomas Ernst, Gesine Kögler, Andreas Krieg, Steffen Lüdeke, Hana Kunkel, Ana J. Rodrigues Moita, Matthias U. Kassack, Viktoria Marquardt, Friederike V. Opitz, Marina Oldenburg, Marc Remke, Florian Babor, Manuel Grez, Andreas Hochhaus, Arndt Borkhardt, Georg Groth, Luitgard Nagel-Steger, Joachim Jose, Thomas Kurz, Holger Gohlke, Finn K. Hansen, Julia Hauer
Journal: Blood
Blood (2018) 132 (3): 307–320.
https://doi.org/10.1182/blood-2017-10-810986
Published: 2018
Includes: Supplemental data
Journal Articles

In Vivo RNAi Screening Identifies HDAC4 As a Mediator Of Chemoresistance In Acute Myeloid Leukemia

Stephanie Lettermann, Konstantin Agelopoulos, Christian Rohde, PhD, Beate Lindtner, Linda Marek, Georg Hempel, Matthias Stelljes, MD, Wolfgang E. Berdel, MD, Thomas Kurz, Carsten Müller-Tidow, MD
Journal: Blood
Blood (2013) 122 (21): 1257.
https://doi.org/10.1182/blood.V122.21.1257.1257
Published: 2013